Tobacco use assessment, brief counseling,, and quit line referral

Similar documents
Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Smoking Cessation Strategies: What Works?

Effective Treatments for Tobacco Dependence

You Can Make a Difference!

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

Pharmacologic Therapy for Tobacco Use & Dependence

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

Smoking Cessation Services Guidance

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

SMOKING CESSATION. Recommendations 5As Approach to Smoking Cessation. Stages of Change Assisting the Smoker. Contributor Dr. Saifuz Sulami.

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019

Pharmacotherapy for Treating Tobacco Dependence

What is Quitline Iowa?

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE

Chantix Label Update 2018

Dispensing of Nicotine Replacement Therapy (NRT)

MassHealth Tobacco Cessation Program Benefit

Addressing Tobacco Use in Iowa

Cessation Medicine Reference Guide Table of Contents

5. Offer pharmacotherapy to all smokers who are attempting to quit, unless contraindicated.

Tobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota

Tobacco Use Dependence and Approaches to Treatment

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA

Addressing Tobacco It Takes a Village

Tobacco & Nicotine: Addiction and Treatment

Over the Road Truck Driver Who Smokes

Treating Tobacco Use:

The Science and Practice of Perinatal Tobacco Use Cessation

Best Practices in Tobacco Treatment IDN

Tobacco Dependence Treatment: A Resource Guide. Last Update: 06/2013

My Mask. I keep it all inside. Because I d rather. The pain destroy me. Than everyone else. Anon.

BASIC SKILLS FOR WORKING WITH SMOKERS

Pharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation

Smoking cessation therapy

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Management of Perinatal Tobacco Use

4/2/2015. Inpatient Smoking Cessation. Smoking Cessation Documentation Patient's Stage of Behavior Change

ALL QUITLINE FACTS: An Overview of the NAQC 2009 Annual Survey of Quitlines

NYSMPEP Smoking Cessation Guidance: Key Message 3

Nicotine Replacement and Smoking Cessation: Update on Best Practices

Introduction to pharmacotherapy

BASIC SKILLS FOR WORKING WITH SMOKERS

Drug Use Evaluation: Smoking Cessation

Tobacco Cessation, E- Cigarettes and Hookahs

Adolescents and Tobacco Cessation

2018 Tobacco/Smoke Free Affidavit

Background. Abstinence rates associated with varenicline

Brief Intervention for Smoking Cessation. National Training Programme

Pharmacotherapy for Tobacco Dependence Treatment

PHARMACOTHERAPY OF SMOKING CESSATION

Tobacco Cessation: Priority for Health Providers. Acknowledgements. Tobacco Cessation: Secondhand Smoke. Smoke-Free Environment & CA

Formulary and Prescribing Guidelines

See Important Reminder at the end of this policy for important regulatory and legal information.

Patient Group Direction for the Supply of Varenicline (Champix ) by Authorised Community Pharmacists

Tobacco Use: Screening & Cessation Intervention

Addressing Smoking Among Individuals with Behavioral Health Issues

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2001

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

Smoking Cessation: Treating Tobacco Dependence

A new model for prescribing varenicline

SECTION 17: NICOTINE REPLACEMENT. Formulary and Prescribing Guidelines

Smoking Cessation and the Pharmacist

7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING CHALLENGE 7 DAY QUIT SMOKING PDF YOU CAN QUIT SMOKING. QUIT SMOKING CDC 1 / 5

Session 1: Days 1-3. Session 4: Days Session 2: Days 4-7. Session 5: Days Session 3: Days Day 21: Quit Day!

NAQC Conference 2017 Lunch Plenary

The Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006

St. Joseph s Health PROVIDER BRIEF. Tobacco Dependence Treatment Guidelines Perinatal and Postpartum Women

RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits

Legacy Emanuel Medical Center Nicotine Withdrawal Prevention Protocol (NicWiPP) Provider Education

Varenicline and Other Pharmacotherapies for Tobacco Dependence

A systems approach to treating tobacco use and dependence

Smoking Cessation Strategies in 2017

Month/Year of Review: March 2014 Date of Last Review: April 2012

Effective date: October 15, 2009

Evaluation of Colorado QuitLine outcomes among FY enrollees. January 2012

The Kentucky Department for Public Health University of Kentucky College of Nursing Knox County Health Department Tobacco Cessation Survey, 2001

Interventions in the Hospital Setting

PRENATAL/POSTPARTUM SURVEY FOR HEALTH DEPARTMENT STAFF

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Treating Tobacco Use and Dependence

Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking. Getting Ready to Quit Course

Asthma Educator Sharing Day October 28, 2016

Closing the Gap: Treatment of Tobacco Dependence

Smoking Cessation for Persons with Serious Mental Illness

Reducing Tobacco Use and Secondhand Smoke Exposure: Quitline Interventions. Summary Evidence Table: Provider Referral to Promote Quitline Use

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

See Important Reminder at the end of this policy for important regulatory and legal information.

Aspirin. Iron Supplements

Update on Medications for Tobacco Cessation

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

Collaborating to help Oregon tobacco users quit

Transcription:

Tobacco use assessment, brief counseling,, and quit line referral What is the evidence for tobacco cessation counseling? Tobacco use is the leading cause of preventable death in the US 1 Counseling and pharmacotherapy can double quit rates 2 Brief clinical interventions are effective 3 Why are we doing this now? Over 76% of our patients 12 years and older are screened for tobacco use when they come in for visits. 35% of those screened use tobacco. Counseling /treatment services are available, but not routinely offered: o Quit Lines provide in depth coaching and support for quitting. o Tobacco cessation products are available through most payors Giving tobacco counseling is a nationally and locally well-accepted quality metric How was the process created? This process was initially created by a multidisciplinary group of staff from across clinics, then piloted at mid-county health center in January 2013. Goals of this process: 1) Screen all patients 12 and older for tobacco use 2) Counsel every tobacco user at every visit. 3) Create a standard definition of counseling 4) Connect every patient who is ready to quit to resources for smoking cessation Key Metrics: o % of active patients (patients seen in the last year) 12 and older who were screened for tobacco use 1 CDC MMWR 1993 2 A clinical practice guideline for treating tobacco use and dependence. 2000 3 Treating Tobacco Use and Dependence Clinical Practice Guideline, U.S. Department of Health and Human Services, Public Health Service, May 2008 1

o % of patients who screen positive for tobacco use who are given counseling at the last visit. Overview 4 : Oregon Quit Line TCA / MA Provider Person rooming patient Details Step 1: Tobacco Screening Person rooming the patient determines patient readiness to quit, documents, orders and pends referral. 4 Overview 1 pager Cheat Sheet found in Annex 2, p. 14 4 CDC MMWR 1993 4 Fiore A clinical practice guideline for treating tobacco use and dependence. 2000 4 USPSTF 2003 2

a) Person rooming the patient asks if they use tobacco. The answer is documented in the vitals section of the chart. Person rooming the patient asks if it would be okay to talk about cutting back. If the patient answers, yes this is indicated in the vitals section of the chart (as ready to quit). If the patient answers, no this is indicated in the vitals section of the chart (as not ready to quit). Person rooming the patient clicks on Mark as Reviewed when they are finished. 3

b) Person rooming the patient Orders and Pends a referral to the Oregon Quit Line using referral #9077 for smoking cessation. c) Person rooming the patient uses smartphrases.mcrtq or.mcnrtq in progress notes..mcrtq = patient ready to discuss options for quitting.mcnrtq = patient declines discussing options for quitting 4

Step 2 Step 2: : Provider or CHN counsels patient on quitting use of tobacco products; Provider or CHN documents counseling in Vitals & Progress Notes. 5

Provider or CHN documents counselingc in Vitals: Provider or CHN documents how counseling was giving in Progress Notes: Type.tobacco and choose referred to Stop Smoking Clinic / Program or provided smoking cessation counseling **Note: Even if patient is not interested in quitting or cutting back at this time, counseling should still be provided per workflow above. 6

Step 3: Patient agrees to Quit Line referral and provider signs the order a) If patient does not agree, the referral process stops here and is documented in progress notes. OR b) If the patient does agree, provider signs the order and process is documented in progress notes. c) If the patient agrees, but does not want to work with Oregon Quit Line, the provider makes arrangements to follow-up with the patient at 1 week and 1 month. **Note: Inform patient that if they are covered by Family Care insurance, they are required to do the Quit Line coaching to receive more than 14 days of medication to help them quit. Quitline Referral ing 7

Step 4: TCA / MA completes Quit Line referral letter with patient TCA or MA sees referral order for the Quit Line which prompts them to: a) TCA closes referral when it appears in queue. b) Fill in and Print Oregon Quit Line fax referral letter19021 from letter templates c) **Before the patient leaves, the TCA / MA has the patient initial & sign the letter and circle best times to be contacted on the form d) Make sure patient knows that if they are covered by Family Care insurance, they are required to do the quit line coaching to receive more than 14 days of medication to help them quit. The provider should already have told them this. 8

9

Step 5: TCA / MA faxes referral letter to the Oregon Quit Line & closes referral. a) TCA / MA faxes referral letter to the Oregon Quit Line at the # on the form (1-800-483 483-3114). 3114). b) TCA / MA sends signed letter to scanning. Step 6: TCA / MA receives report, & gives report to provider and panel manager The Oregon Quit Line may still be working with the patient but progress to date is sent at the 1 month point. If the 1 month report is not received the TCA / MA should contact: Beth Sanders Cessation Coordinator (971) 673-0563 elizabeth.c.sanders@state.or.us 10

Example of Fax Referral Reports Step 7: Panel Manager enters details in problem list The report includes details such as whether the patient was reached and if they enrolled or declined services. These details should be included in the problem list for the patient. **If you have updates or questions regarding this Job Aid, contact Health Promotion Coordinator Sylvia Ness (sylvia.ness@multco.us, ext. 25445) 11

Appendix ppendix1: SMOKING CESSATION PRODUCTS / MEDICATIONS Evidence Summary Strong evidence All FDA-approved smoking cessation products are > placebo NRT and bupropion (Zyban) are equally effective Combining the NRT patch with another NRT therapy (e.g. gum) > NRT monotherapy Combining behavioral therapy with smoking cessation products increase the rate of long-term (> 6 mo) abstinence Moderate to Strong Evidence Varencicline (Chantix) has higher abstinence rates than bupropion or NRT Inconclusive Evidence Combining bupropion with NRT Use of any product in: pregnant women, adolescents, smokeless tobacco users, and light smokers who smoke < 10 cigarettes/day Nicotine Replacement Therapy Patch, gum and lozenge minimize withdrawal sxs; all except patch help with immediate cravings Intended for short-term use (12-24 weeks or less) No differences in safety or efficacy between NRT products (strong evidence) Nasal spray and inhaler - by Rx only; all others OTC Use with caution in patients with CVD- particularly recent MI, arrhythmia, serious/worsening angina Pregnancy Cat: D Common AE: local irritation Bupropion SR (Zyban) Increases seizure threshold; avoid in patients prone to seizures Blackbox warning: risk of serious MH events including behavior change, depression, hostility, and SI Pregnancy Cat: C Common AE: insomnia*, dry mouth Varencicline (Chantix) Highest abstinence rates Blackbox warning: risk of serious MH events including behavior change, depression, hostility, and SI Reduce dose in renal dysfunction (CrCl < 30ml/min) and dialysis Use with caution in pts with CVD- may increase risk of serious CV events (inconclusive evidence) Pregnancy Cat: D Common AE: nausea, insomnia*, headache *Taking the 2 nd dose in the late afternoon (> 8hrs after the 1 st dose) or earlier in the evening with dinner helps minimize. 12

Oregon Tobacco Quit Line Provides free counseling to all Oregonians. Hours: 7 days/wk, 4:00 AM To 12:00 AM (Pacific Time) Formulary Coverage Product MCHD Uninsured OHP Open-Card CareOregon OHP FamilyCare (FC) OHP Nicotine patch No QL Total of 60 patches/yr QL 14d supply/rx & total of 98d All products covered. supply/yr (i.e. 6 mo supply /yr) Nicotine gum No QL Total of 3600 Nicotine lozenge No pieces/yr (i.e. 6 mo supply/yr) Nicotine inhaler No No No Nicotine nasal No No No Bupropion SR 150mg $4 Yes; No QL QL Total of 180d supply/yr Chantix $4 QL 12 wks/6 mo Abbreviations: QL = Quantity Limit QL Total of 90d supply/yr Initial 7d supply allowed. Patient is required to enroll in Alere Wellbeing to get more than 7 days of medication. Alere sends enrollment lists to FC daily and FC enters auth for subsequent Rx fills. Alere Wellbeing Access through fax referral process. Oregon Quit Line triages Family Care clients to Allere services. 13

Annex 2: Tobacco Cessation Workflow CHEAT SHEET Step 1: Tobacco Screening and readiness to quit assessment Person rooming the patient 1) Ask patient ages 12 and up about tobacco use and document on Vital Signs page. If not using tobacco, the process stops here 2) if using tobacco: Ask Is now a good time to discuss quitting? Document patient answer in the READY TO QUIT section. 3) Go to Progress Notes and type in smart phrase.mcrtq or.mcnrtq.mcrtq=patient ready to discuss options for quitting.mcnrtq=patient declines discussing options for quitting 4) If ready to quit, pend order and referral for Tobacco Quit Line to provider using referral #9077 for smoking cessation. Step 2: Counseling Provider 1) Counsel: If NOT ready to quit 5 : Quitting tobacco is one of the most important things you can do to protect your health. We will keep checking with you to see when you are ready to talk about cutting back. If ready to quit: Offer medication and/or counseling support: It can be helpful to have someone coach and support you when you quit. The tobacco Quit Line has great free coaching services I d like to refer you to. Would it be okay if someone from the quit line calls you? 2) sign or delete referral #9077 depending on patient preference. 5 See if patient is ready to quit by: Reviewing progress note by MA (or looking at vitals section) 14

If patient wants to quit but declines the Quit Line, provider or support person will notify CHN to call patient within a week and then a month to follow up with patient. 3) Document a. click Counseling Given section on the Vital Signs page (reported on dashboard) b. document actual counseling in progress notes Step 3: Arranging CMA CMA to print out Oregon Tobacco Quit Line Referral Letter from Letter Templates in EPIC number 19021. Patient to circle best times to be contacted. TCA or CMA will fax signed referral letter to 1-800-483-3114 and then send signed letter to scanning. TCA If order is signed the referral will appear in the Referral Queue for TCA. TCA to close out the referral when it shows up in the queue. Step 4 (optional): Follow up CHN During Follow-up Call CHN will discuss: 1) if patient actually has quit or cut down and 2) how patient is managing with any withdrawal issues. Revisit if patient wants to try Quit Line (if patient is struggling). Schedule patient for 1 more follow up call in a month. 15